Canadian Patent Enhances Market Exclusivity and Licensing Potential Expands Global Intellectual Property Portfolio Supporting Long-Term Revenue Growth VANCOUVER, BC / ACCESS Newswire / January 7, 2026 / Ovation Science Inc. (CSE: OVAT )(OTC PINK: OVATF ) ("Ovation" or the "Company"), a research and development company focused on the commercialization, patenting, and licensing of advanced cannabinoid-based topical /... Read More

VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / December 22, 2025 / Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation" or the "Company") welcomes the recent U.S. rescheduling of cannabis and the potential introduction of a Medicare program that could allow patient access to much-needed, potentially life-changing CBD therapies, including topical formulations. Ovation's science-based topical / transdermal cannabis... Read More

VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / September 18, 2025 / Ovation Science Inc. ( CSE:OVAT)(OTC:OVATF ) ("Ovation" or the "Company"), today announced an enhanced strategic partnership with Skinvisible Pharmaceuticals, Inc. (OTCQB:SKVI) ("Skinvisible") to leverage patent-pending Invisicare ® topical and transdermal cannabis developments in the obesity market. The agreement will enhance the strategic partnership... Read More

Expanded License Agreement Brings Ovation's Science-Based Topicals to Largest Medical Cannabis Market in the USA VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / July 29, 2025 / Ovation Science Inc. ( CSE:OVAT)(OTC:OVATF ) ("Ovation" or the "Company"), today announced an expanded license agreement with Planet 13 Holdings, Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13") to bring its patented Invisicare® topical and transdermal... Read More

VANCOUVER, BC / ACCESSWIRE / December 4, 2024 / (CSE:OVAT)(OTC PINK:OVATF) - Ovation Science Inc. ("Ovation" or the "Company"), with its patented topical and transdermal cannabis products powered by its proprietary skin delivery technology Invisicare®, announces the official launch of its products in Pennsylvania through its licensee: PA Options for Wellness Inc. ("PA Options"). The launch marks Ovation's second licensee in... Read More

VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / April 30, 2024 / Ovation Science Inc. ("Ovation" or the "Company") (CSE:OVAT) (OTCQB:OVATF), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare ® , today announced the official launch of its topical product line in Nevada with Planet 13 Holdings, Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13"). These products will... Read More

VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / April 11, 2024 / (CSE:OVAT)(OTCQB:OVATF) - Ovation Science Inc. ("Ovation" or the "Company"), with its patented topical and transdermal cannabis products powered by its skin delivery technology Invisicare®, is pleased to announce the signing of an exclusive licensing agreement for Ovation's products for Canada with Ripco Processing Inc. ("Ripco"); a company based in Calgary,... Read More

VANCOUVER, BC and LAS VEGAS , Nov. 2, 2023 /CNW/ - (CSE: OVAT) (OTCQB: OVATF) – Ovation Science USA Inc. ("Ovation" or the "Company"), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare®, today announced the signing of an exclusive licensing agreement for Ovation's topical / transdermal formulations for the state of Missouri . The Company's new licensee... Read More

VANCOUVER, BC and LAS VEGAS , Sept. 11, 2023 /CNW/ - (CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare ® , today announced the signing of an exclusive licensing agreement with Planet 13 Holdings, Inc. (CSE: PLTH) (OTCQX: PLNHF) ("Planet 13") , a leading vertically-integrated... Read More

VANCOUVER, BC and LAS VEGAS , May 24, 2023 /CNW/ - (CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare®, is pleased to announce it has entered into an exclusive licensing agreement with PA Options for Wellness Inc. ("PA Options") for Pennsylvania . PA Options, founded in 2014,... Read More

Ovation Topical CBD Products to Be Sold in the USA , UK and Europe VANCOUVER, BC and LAS VEGAS , March 28, 2023 /CNW/ - (CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, announces it has signed a Supply and Distribution Agreement with Golfer's CBD Ltd., an international CBD brand... Read More

Ovation Science Inc. ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare ® , today announced it will be participating and be taking new licensee meetings at the MJ Unpacked conference being held at the MGM Hotel in Las Vegas from September 28 to 30th, 2022 . Ovation will participate as an exhibitor (Booth 218) and management will be... Read More

Patent Protection Until 2041 Awarded for Transdermal Creams Formulated with CBD and THC Ovation Science Inc . ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has granted Ovation a patent entitled "Composition and Method for Transdermal Delivery of... Read More

Ovation Formulations Soon to be Potentially Available in Over 2800 Dispensaries Ovation Science Inc. ("Ovation" or the "Company") a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, is pleased to announce it has entered into an exclusive licensing agreement for its cannabis formulations for the states of Oklahoma , Missouri , New Mexico and Mississippi with... Read More

New High Dose CBD Formulations Developed As CBD Market Flourishes Ovation Science Inc. (CSE: OVAT) (OTCQB: OVATF) ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, announces that it... Read More

Third Quarter Results Driven by 15% Increase in Royalty Revenue and Strong Fourth Quarter Ovation Science Inc. (CSE: OVAT) (OTCQB: OVATF) ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and... Read More

On-going Pandemic Has Raised Importance for Employers to Implement Preventive Measures Ovation Science Inc. (CSE:OVAT) (OTCQB:OVATF) ("Ovation" or the "Company") is pleased to announce it has secured Pivot Protection Resource as a new national distributor for its non-alcohol hand sanitizer lotion, DermSafe®. Pivot Protection will be targeting their extensive business contacts across Canada. This Canadian PPE company, with... Read More

Return to Sports Begins as Canada Opens Up Ovation Science Inc. (CSE:OVAT)(OTC:OVATF) ("Ovation" or the "Company") is pleased to announce an increase in the sale of its non-alcohol hand sanitizer lotion, DermSafe® to professional and amateur athletes across Canada. Whether it's for athletes traveling locally or internationally or local junior baseball or any teams, the benefit of using a non-alcohol hand sanitizer is... Read More

Ovation Science Inc. (CSE:OVAT) (OTCQB:OVATF) ("Ovation" or the "Company") announces it has begun an online campaign to promote its DermSafe® hand sanitizer made without alcohol and powered by the Company's Invisicare® drug delivery technology. The campaign will be featured on the Canadian Skin Information's two key websites which attract over 25 thousand visitors per month. The aim of the campaign is to introduce the unique... Read More

Ovation Science Inc. (CSE:OVAT)(OTCQB:OVATF)("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, is pleased to provide this update on the ongoing research and development of its topical and transdermal cannabis products using its patented skin delivery technology Invisicare®. Since its... Read More

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced the addition of Ovation Science Inc. (CSE: OVAT) (OTCQB: OVATF) to its growing client roster. Ovation Science Inc. CFN Media will leverage its... Read More

Continued Strength Shown As Demand for Cannabis Increases Ovation Science Inc. (CSE:OVAT) (OTCQB:OVATF) ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, reports that sales in January 2021 through its licensee in Nevada outperformed the previous month (December 2020) by over 70%.... Read More

Ovation Science Inc. (CSE: OVAT) (OTCQB: OVATF) ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, reports that sales in January 2021 through its licensee in Nevada outperformed the... Read More

Ovation Science Inc. (CSE:OVAT) (OTCQB:OVATF) ("Ovation" or the "Company"), a topical and transdermal cannabis product development company with a patented skin delivery technology and backed by over twenty years of research and development, is pleased to announce it has secured a U.S. listing on the OTCQB ("OTCQB Market") under the symbol OVATF. Shares will begin trading as of February 23, 2021 and will allow for greater... Read More

Ovation Science Inc. (CSE:OVAT) (OTC PINK:OVATF) ("Ovation" or the "Company") is pleased to announce it has entered into a non-exclusive distribution agreement for its DermSafe® hand sanitizer with CDMV, Canada's leading distributor of products to veterinary clinics across Canada. CDMV, established in 1972, is the largest provider of products and services to veterinary clinics across Canada and has four distribution centers... Read More

Ovation Science Inc. (CSE:OVAT) and (OTC PINK:OVATF) ("Ovation" or the "Company") is pleased to announce it has received a further order for its DermSafe® hand sanitizer lotion from its distributor, Grupo Venta International, S.A. de C.V. ("Grupo Venta"), with corporate offices in Guadalajara, Mexico. They have been successfully selling DermSafe personal use sized bottles through-out Mexico and this new order represents a... Read More